MELISSA BUCHANAN: Open Payments
NPI 1730465113 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,083 in 39 payments from 8 companies in 2025. Trend: 2023 $8,178 · 2024 $1,158 · 2025 $3,083
Speaker / faculty: $1,875Food & beverage: $1,208
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $2,080 |
| SCPHARMACEUTICALS INC. | 3 | $263 |
| Novartis Pharmaceuticals Corporation | 19 | $260 |
| CVRx, Inc. | 3 | $146 |
| Kestra Medical Technology Services, Inc. | 4 | $144 |
| Actelion Pharmaceuticals US, Inc. | 1 | $135 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: REPATHA, FUROSCIX, LEQVIO, Barostim Neo System, Assure WCD, UPTRAVI, CAMZYOS.
Industry payments across FL — which companies pay providers there.
